Vanguard Capital Management’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
Other funds holding GLSI
Vanguard Capital Management's GLSI Position: Q3 2026 in Review
Vanguard Capital Management increased its Greenwich LifeSciences (GLSI) stake by 3.7% in Q3 2026, buying an estimated $174K and bringing the position to 288,610 shares worth $5.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3067.
Vanguard Capital Management first reported a position in GLSI in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.16M in Q1 2026. 42 funds tracked by Wall St. Rank hold GLSI as of Q3 2026.
- Vanguard Capital Management held 288,610 shares of Greenwich LifeSciences worth $5.21M as of Q3 2026.
- Vanguard Capital Management bought 10,420 Greenwich LifeSciences shares in Q3 2026, an estimated $174K.
- Greenwich LifeSciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3067 holding.
- Vanguard Capital Management first reported a position in Greenwich LifeSciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Greenwich LifeSciences position peaked at $7.16M in Q1 2026.
- 42 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.